Free Trial

Barclays (BCS) 10K Form and Latest SEC Filings 2026

Barclays logo
$24.56 +0.22 (+0.88%)
As of 02:49 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Latest Barclays SEC Filings & Recent Activity

Barclays (NYSE:BCS) has submitted 984+ documents to the U.S. Securities and Exchange Commission (SEC) since 2017. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Barclays's financial statements. The most recent filing was a Form 6-K submitted on May 26, 2026.

20-F
Barclays Files Annual Report on Feb. 10, 2026

The 20-F contains Barclays's audited financial statements, revenue, earnings, and risk factors for the prior fiscal year.

View earnings history

Barclays SEC Filing History

Browse Barclays' complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
05/26/2026 12:24 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2026 10:32 AM
Barclays (312069) Filed by
XANADU QUANTUM TECHNOLOGIES FORMER SPAC INC. (2054174) Subject
XANADU QUANTUM TECHNOLOGIES FORMER SPAC INC. (2054174) Subject
Form SCHEDULE 13G/A
05/15/2026 7:40 AM
Barclays (312069) Filed by
Centurion Acquisition Corp. (2010930) Subject
Centurion Acquisition Corp. (2010930) Subject
Form SCHEDULE 13G
05/14/2026 8:52 PM
Barclays (312069) Filed by
Range Capital Acquisition Corp. (2035644) Subject
Range Capital Acquisition Corp. (2035644) Subject
Form SCHEDULE 13G/A
05/14/2026 8:46 PM
Barclays (312069) Filed by
Talkspace, Inc. (1803901) Subject
Talkspace, Inc. (1803901) Subject
Talkspace, Inc. (1803901) Subject
Form SCHEDULE 13G
05/14/2026 8:22 PM
Barclays (312069) Filed by
Calisa Acquisition Corp (2026767) Subject
Calisa Acquisition Corp (2026767) Subject
Calisa Acquisition Corp (2026767) Subject
Form SCHEDULE 13G
05/14/2026 8:23 PM
Barclays (312069) Filed by
SilverBox Corp IV (2015947) Subject
Form SCHEDULE 13G
05/14/2026 8:23 PM
Barclays (312069) Filed by
Graf Global Corp. (1897463) Subject
Form SCHEDULE 13G
05/14/2026 8:24 PM
Andretti Acquisition Corp. II (2025341) Subject
Andretti Acquisition Corp. II (2025341) Subject
Barclays (312069) Filed by
Form SCHEDULE 13G/A
05/14/2026 8:25 PM
Barclays (312069) Filed by
Gores Holdings X, Inc. / CI (1986817) Subject
Gores Holdings X, Inc. / CI (1986817) Subject
Form SCHEDULE 13G
05/14/2026 8:25 PM
Barclays (312069) Filed by
BEL FUSE INC /NJ (729580) Subject
BEL FUSE INC /NJ (729580) Subject
Form SCHEDULE 13G
05/14/2026 8:25 PM
Barclays (312069) Filed by
REVIVA PHARMACEUTICALS HOLDINGS, INC. (1742927) Subject
REVIVA PHARMACEUTICALS HOLDINGS, INC. (1742927) Subject
Form SCHEDULE 13G
05/14/2026 8:26 PM
Barclays (312069) Filed by
MERCER INTERNATIONAL INC. (1333274) Subject
Form SCHEDULE 13G
05/14/2026 8:27 PM
Barclays (312069) Filed by
Star Holdings (1953366) Subject
Form SCHEDULE 13G/A
05/14/2026 8:27 PM
AMICUS THERAPEUTICS, INC. (1178879) Subject
Barclays (312069) Filed by
Form SCHEDULE 13G
05/14/2026 8:28 PM
Barclays (312069) Filed by
MASIMO CORP (937556) Subject
Form SCHEDULE 13G
05/14/2026 8:29 PM
Barclays (312069) Filed by
Tavia Acquisition Corp. (2020385) Subject
Tavia Acquisition Corp. (2020385) Subject
Form SCHEDULE 13G
05/14/2026 8:31 PM
Barclays (312069) Filed by
JELD-WEN Holding, Inc. (1674335) Subject
Form SCHEDULE 13G
05/14/2026 7:38 PM
Barclays (312069) Filed by
Lakeshore Acquisition III Corp. (2049248) Subject
Lakeshore Acquisition III Corp. (2049248) Subject
Lakeshore Acquisition III Corp. (2049248) Subject
Form SCHEDULE 13G
05/14/2026 7:40 PM
Barclays (312069) Filed by
Odysseus (0) Cayman
Form SCHEDULE 13G/A
05/14/2026 7:40 PM
Barclays (312069) Filed by
RADCOM LTD (1016838) Subject
Form SCHEDULE 13G/A
05/14/2026 7:41 PM
Barclays (312069) Filed by
Soulpower Acquisition Corp. (2025608) Subject
Form SCHEDULE 13G/A
05/14/2026 7:42 PM
Barclays (312069) Filed by
SHENANDOAH TELECOMMUNICATIONS CO/VA/ (354963) Subject
Form SCHEDULE 13G/A
05/14/2026 7:43 PM
Barclays (312069) Filed by
Melar Acquisition Corp. I/Cayman (2016221) Subject
Melar Acquisition Corp. I/Cayman (2016221) Subject
Form SCHEDULE 13G/A
05/14/2026 7:44 PM
Barclays (312069) Filed by
Cantor Equity Partners II, Inc. (2034269) Subject
Form SCHEDULE 13G/A
05/14/2026 7:47 PM
Barclays (312069) Filed by
James River Group Holdings, Inc. (1620459) Subject
Form SCHEDULE 13G/A
05/14/2026 7:48 PM
Barclays (312069) Filed by
PHIBRO ANIMAL HEALTH CORP (1069899) Subject
Form SCHEDULE 13G/A
05/14/2026 7:49 PM
Barclays (312069) Filed by
WEN Acquisition Corp (2057043) Subject
Form SCHEDULE 13G/A
05/14/2026 7:50 PM
Barclays (312069) Filed by
Centurion Acquisition Corp. (2010930) Subject
Centurion Acquisition Corp. (2010930) Subject
Form SCHEDULE 13G/A
05/14/2026 7:34 PM
Barclays (312069) Filed by
CO2 Energy Transition Corp. (1956648) Subject
CO2 Energy Transition Corp. (1956648) Subject
CO2 Energy Transition Corp. (1956648) Subject
Form SCHEDULE 13G
05/14/2026 7:34 PM
Barclays (312069) Filed by
Madison Square Garden Entertainment Corp. (1952073) Subject
Form SCHEDULE 13G
05/12/2026 1:44 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/12/2026 1:06 PM
Barclays (312069) Filed by
EVERSPIN TECHNOLOGIES INC. (1438423) Subject
Form SCHEDULE 13G/A
05/12/2026 10:34 AM
Barclays (312069) Subject
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Form 25-NSE
05/11/2026 10:30 AM
Barclays (312069) Subject
NEW YORK STOCK EXCHANGE LLC (876661) Filed by
Form 25-NSE
05/07/2026 1:58 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2026 12:13 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2026 12:54 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2026 5:19 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/28/2026 6:00 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/13/2026 12:37 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Before you buy SpaceX shares, consider this alternative approach (Ad)

SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.tc pixel

Discover the overlooked SpaceX IPO strategy before the June listing
04/07/2026 3:02 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2026 6:41 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/31/2026 2:11 PM
Barclays (312069) Filer
Form 13F-HR/A
03/31/2026 10:10 AM
Barclays (312069) Filer
Form 13F-HR/A
03/30/2026 7:05 AM
Barclays (312069) Filer
Form 13F-HR/A
03/30/2026 7:11 AM
Barclays (312069) Filer
Form 13F-HR/A
03/30/2026 7:11 AM
Barclays (312069) Filer
Form 13F-HR/A
03/27/2026 7:17 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2026 5:52 AM
Barclays (312069) Filer
Form 13F-HR/A
03/24/2026 1:30 PM
Barclays (312069) Filer
Form 13F-HR/A
03/23/2026 12:21 PM
Barclays (312069) Filer
Form 13F-HR/A
03/19/2026 4:15 PM
Barclays (312069) Filer
Form 13F-HR/A
03/19/2026 3:01 PM
Barclays (312069) Filer
Form 13F-HR/A
03/18/2026 1:18 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/17/2026 10:03 AM
Barclays (312069) Filer
Form 13F-HR/A
03/12/2026 3:25 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2026 6:49 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2026 6:53 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2026 9:55 AM
Barclays (312069) Filer
Form CERT
03/02/2026 9:34 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2026 3:42 PM
Barclays (312069) Filer
Form 8-A12B
02/24/2026 2:11 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/19/2026 1:43 PM
Barclays (312069) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
02/18/2026 6:50 AM
Barclays (312069) Subject
Form FWP
02/18/2026 6:41 AM
Barclays (312069) Subject
Form FWP
02/18/2026 6:45 AM
Barclays (312069) Subject
Form FWP
02/18/2026 6:47 AM
Barclays (312069) Subject
Form FWP
02/17/2026 8:29 AM
Barclays (312069) Filer
Form 424B2
Transaction specifc information for a delayed shelf offering
02/13/2026 4:39 PM
Barclays (312069) Filed by
Launch One Acquisition Corp. (2015502) Subject
Launch One Acquisition Corp. (2015502) Subject
Form SCHEDULE 13G/A
02/13/2026 4:40 PM
Barclays (312069) Filed by
LightWave Acquisition Corp. (2061379) Subject
LightWave Acquisition Corp. (2061379) Subject
Form SCHEDULE 13G/A
02/13/2026 4:41 PM
Barclays (312069) Filed by
Blue Water Acquisition Corp. III (2050501) Subject
Blue Water Acquisition Corp. III (2050501) Subject
Form SCHEDULE 13G/A
02/13/2026 2:22 PM
Barclays (312069) Filed by
DT Cloud Star Acquisition Corp (2017950) Subject
DT Cloud Star Acquisition Corp (2017950) Subject
DT Cloud Star Acquisition Corp (2017950) Subject
Form SCHEDULE 13G/A
02/12/2026 6:16 AM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2026 4:12 PM
Barclays (312069) Filed by
INFLECTION POINT ACQUISITION CORP. IV (2028707) Subject
INFLECTION POINT ACQUISITION CORP. IV (2028707) Subject
INFLECTION POINT ACQUISITION CORP. IV (2028707) Subject
Form SCHEDULE 13G
02/11/2026 3:39 PM
Barclays (312069) Filed by
RADCOM LTD (1016838) Subject
Form SCHEDULE 13G/A
02/11/2026 3:13 PM
Barclays (312069) Filed by
GCI Liberty, Inc. (2057463) Subject
Form SCHEDULE 13G/A
02/11/2026 3:17 PM
Barclays (312069) Filed by
Cartesian Growth Corp III (2049662) Subject
Cartesian Growth Corp III (2049662) Subject
Form SCHEDULE 13G/A
02/11/2026 2:49 PM
Barclays (312069) Filed by
EQV Ventures Acquisition Corp. (2021042) Subject
Form SCHEDULE 13G/A
02/11/2026 2:53 PM
Barclays (312069) Filed by
Sizzle Acquisition Corp. II (2030663) Subject
Form SCHEDULE 13G/A
02/11/2026 2:23 PM
Axiom Intelligence Acquisition Corp 1 (2057030) Subject
Axiom Intelligence Acquisition Corp 1 (2057030) Subject
Axiom Intelligence Acquisition Corp 1 (2057030) Subject
Barclays (312069) Filed by
Form SCHEDULE 13G/A
02/11/2026 2:27 PM
Barclays (312069) Filed by
PANTAGES CAPITAL ACQUSITION Corp (2030829) Subject
PANTAGES CAPITAL ACQUSITION Corp (2030829) Subject
PANTAGES CAPITAL ACQUSITION Corp (2030829) Subject
Form SCHEDULE 13G/A
02/11/2026 2:30 PM
Barclays (312069) Filed by
Legato Merger Corp. III (2002038) Subject
Form SCHEDULE 13G/A
02/11/2026 2:34 PM
Archimedes Tech SPAC Partners II Co. (2028516) Subject
Archimedes Tech SPAC Partners II Co. (2028516) Subject
Barclays (312069) Filed by
Form SCHEDULE 13G/A
02/11/2026 2:08 PM
Barclays (312069) Filed by
CO2 Energy Transition Corp. (1956648) Subject
CO2 Energy Transition Corp. (1956648) Subject
CO2 Energy Transition Corp. (1956648) Subject
Form SCHEDULE 13G/A
02/11/2026 2:12 PM
Barclays (312069) Filed by
Texas Ventures Acquisition III Corp (2033991) Subject
Texas Ventures Acquisition III Corp (2033991) Subject
Form SCHEDULE 13G/A
02/11/2026 2:18 PM
Barclays (312069) Filed by
Columbus Acquisition Corp/Cayman Islands (2028201) Subject
Columbus Acquisition Corp/Cayman Islands (2028201) Subject
Form SCHEDULE 13G/A
02/11/2026 12:54 PM
Barclays (312069) Filer
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/11/2026 11:24 AM
Barclays (312069) Filed by
Crane Harbor Acquisition Corp. (2054174) Subject
Crane Harbor Acquisition Corp. (2054174) Subject
Form SCHEDULE 13G/A
02/11/2026 11:25 AM
Barclays (312069) Filed by
Launch Two Acquisition Corp. (2023676) Subject
Launch Two Acquisition Corp. (2023676) Subject
Form SCHEDULE 13G
02/11/2026 11:26 AM
Barclays (312069) Filed by
Crown Reserve Acquisition Corp. I (2070887) Subject
Crown Reserve Acquisition Corp. I (2070887) Subject
Crown Reserve Acquisition Corp. I (2070887) Subject
Crown Reserve Acquisition Corp. I (2070887) Subject
Form SCHEDULE 13G
ALERT: Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.tc pixel

02/11/2026 11:28 AM
Andretti Acquisition Corp. II (2025341) Subject
Andretti Acquisition Corp. II (2025341) Subject
Barclays (312069) Filed by
Form SCHEDULE 13G
02/11/2026 10:54 AM
Barclays (312069) Filed by
D. Boral ARC Acquisition I Corp. (2065779) Subject
D. Boral ARC Acquisition I Corp. (2065779) Subject
D. Boral ARC Acquisition I Corp. (2065779) Subject
Form SCHEDULE 13G/A
02/11/2026 11:05 AM
Barclays (312069) Filed by
Gesher Acquisition Corp. II (2044635) Subject
Gesher Acquisition Corp. II (2044635) Subject
Gesher Acquisition Corp. II (2044635) Subject
Form SCHEDULE 13G/A
02/11/2026 11:06 AM
Barclays (312069) Filed by
JENA ACQUISITION Corp II (2060337) Subject
Form SCHEDULE 13G/A
02/11/2026 11:11 AM
Barclays (312069) Filed by
Oyster Enterprises II Acquisition Corp (2042182) Subject
Form SCHEDULE 13G/A
02/11/2026 11:12 AM
Barclays (312069) Filed by
VANTAGE DRILLING INTERNATIONAL (1465872) Subject
Form SCHEDULE 13G/A
02/11/2026 11:14 AM
Barclays (312069) Filed by
Vendome Acquisition Corp I (2055879) Subject
Form SCHEDULE 13G/A
02/11/2026 11:15 AM
Barclays (312069) Filed by
Cal Redwood Acquisition Corp. (2058359) Subject
Cal Redwood Acquisition Corp. (2058359) Subject
Cal Redwood Acquisition Corp. (2058359) Subject
Form SCHEDULE 13G/A
02/11/2026 10:02 AM
Barclays (312069) Filed by
Commerce.com, Inc. (1626450) Subject
Commerce.com, Inc. (1626450) Subject
Form SCHEDULE 13G
(Data available from 1/1/2016 forward)

Barclays SEC Filings - Frequently Asked Questions

Barclays (BCS) has submitted 984+ filings to the SEC since 2017. You can browse the complete history or filter by form type using the tools above.

Barclays's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Barclays's financial statements page.

The most recent filing was a Form 6-K submitted on May 26, 2026. View the full filing using the link above.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


This page (NYSE:BCS) was last updated on 5/29/2026 by MarketBeat.com Staff.
From Our Partners